Lars B. Wadström

1.0k total citations
19 papers, 716 citations indexed

About

Lars B. Wadström is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Rheumatology. According to data from OpenAlex, Lars B. Wadström has authored 19 papers receiving a total of 716 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 6 papers in Surgery and 4 papers in Rheumatology. Recurrent topics in Lars B. Wadström's work include Prostate Cancer Treatment and Research (5 papers), Urinary and Genital Oncology Studies (4 papers) and Bladder and Urothelial Cancer Treatments (3 papers). Lars B. Wadström is often cited by papers focused on Prostate Cancer Treatment and Research (5 papers), Urinary and Genital Oncology Studies (4 papers) and Bladder and Urothelial Cancer Treatments (3 papers). Lars B. Wadström collaborates with scholars based in Sweden and United States. Lars B. Wadström's co-authors include Lars A. Carlson, Sture Falkmer, Lars Grimelius, J. Alumets, Per‐Anders Abrahamsson, Sven Lindstedt, F. Edsmyr, R Pompeius, G. Moberger and P. L. Esposti and has published in prestigious journals such as Nature, American Journal of Clinical Nutrition and The Journal of Urology.

In The Last Decade

Lars B. Wadström

19 papers receiving 629 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lars B. Wadström Sweden 11 188 172 151 138 117 19 716
R. M. Buckle United Kingdom 16 134 0.7× 138 0.8× 80 0.5× 160 1.2× 80 0.7× 43 754
B. McArdle United Kingdom 19 137 0.7× 279 1.6× 49 0.3× 83 0.6× 157 1.3× 39 963
K. R. Bruckdorfer United Kingdom 14 56 0.3× 196 1.1× 102 0.7× 87 0.6× 111 0.9× 33 686
Abraham Borkowski Belgium 14 125 0.7× 174 1.0× 67 0.4× 264 1.9× 120 1.0× 33 845
R Mahler United Kingdom 11 56 0.3× 213 1.2× 145 1.0× 222 1.6× 198 1.7× 38 799
J H Sweiry United Kingdom 14 85 0.5× 265 1.5× 77 0.5× 47 0.3× 240 2.1× 21 801
L. Selmeci Hungary 14 95 0.5× 174 1.0× 103 0.7× 148 1.1× 123 1.1× 51 705
Miho Hida Japan 12 236 1.3× 214 1.2× 63 0.4× 50 0.4× 170 1.5× 39 850
G. J. Johnson United States 15 87 0.5× 135 0.8× 92 0.6× 34 0.2× 131 1.1× 24 830
A. Gougoux Canada 14 106 0.6× 342 2.0× 33 0.2× 71 0.5× 77 0.7× 58 852

Countries citing papers authored by Lars B. Wadström

Since Specialization
Citations

This map shows the geographic impact of Lars B. Wadström's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars B. Wadström with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars B. Wadström more than expected).

Fields of papers citing papers by Lars B. Wadström

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars B. Wadström. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars B. Wadström. The network helps show where Lars B. Wadström may publish in the future.

Co-authorship network of co-authors of Lars B. Wadström

This figure shows the co-authorship network connecting the top 25 collaborators of Lars B. Wadström. A scholar is included among the top collaborators of Lars B. Wadström based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars B. Wadström. Lars B. Wadström is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Abrahamsson, Per‐Anders, Lars B. Wadström, J. Alumets, Sture Falkmer, & Lars Grimelius. (1987). Peptide-Hormone- And Serotonin-Immunoreactive Tumour Cells in Carcinoma of the Prostate. Pathology - Research and Practice. 182(3). 298–307. 125 indexed citations
2.
Lundgren, Rolf, Torsten Sundin, E Lindstedt, et al.. (1987). Cardiovascular Complications of Estrogen Therapy for Nondisseminated Prostatic Carcinoma. A Preliminary Report from a Randomized Multicenter Study. The Journal of Urology. 137(4). 809–809. 1 indexed citations
3.
Lilja, Hans, et al.. (1987). Identification of the three predominant prostatic-secreted proteins and their immunohistochemical localization in normal, hyperplastic and neoplastic prostatic tissue. European Journal of Cancer and Clinical Oncology. 23(8). 1231–1231. 1 indexed citations
4.
Bååth, L., Ulf Nyman, P. Aspelin, & Lars B. Wadström. (1986). Computed Tomography of Pelvic Lipomatosis. Acta Radiologica Diagnosis. 27(3). 311–314. 6 indexed citations
5.
Lundgren, Rolf, Torsten Sundin, S. Colleen, et al.. (1986). Cardiovascular Complications of Estrogen Therapy for Nondisseminated Prostatic Carcinoma: A Preliminary Report from a Randomized Multicenter Study. Scandinavian Journal of Urology and Nephrology. 20(2). 101–105. 22 indexed citations
6.
Abrahamsson, Peter, J. Alumets, Lars B. Wadström, Sture Falkmer, & Lars Grimelius. (1986). Peptide hormones, serotonin, and other cell differentiation markers in benign hyperplasia and in carcinoma of the prostate. European Journal of Cancer and Clinical Oncology. 22(6). 748–748. 2 indexed citations
7.
Wadström, Lars B., et al.. (1986). Peptide-hormone- and serotonin-immunoreactive cells in normal and hyperplastic prostate glands. Pathology - Research and Practice. 181(6). 675–683. 106 indexed citations
8.
Pompeius, R, et al.. (1983). Long‐term urethral catheter drainage and bladder capacity. Neurourology and Urodynamics. 2(2). 135–143. 21 indexed citations
9.
Edsmyr, F., S. Franzén, M. Haverling, et al.. (1972). [Clinical and experimental studies of renal adenocarcinoma].. PubMed. 69(2). 153–67. 2 indexed citations
10.
Edsmyr, F., G. Moberger, & Lars B. Wadström. (1971). Carcinoma of the Bladder: Cystectomy after Supervoltage Therapy. Scandinavian Journal of Urology and Nephrology. 5(3). 215–221. 19 indexed citations
11.
Edsmyr, F., P. L. Esposti, & Lars B. Wadström. (1970). Combined Oestrogen and Supervoltage Radiotherapy in Poorly Differentiated Carcinoma of the Prostate: A Preliminary Report. Scandinavian Journal of Urology and Nephrology. 4(3). 179–181. 7 indexed citations
12.
Russell, R.G.G., Lars B. Wadström, Sandra Lindstedt, et al.. (1969). The origin of inorganic pyrophosphate in urine.. PubMed. 37(2). 419–29. 14 indexed citations
13.
Esposti, P. L., F. Edsmyr, G. Moberger, Lars B. Wadström, & J Zajicek. (1969). The Cytologic Diagnosis of Bladder Tumours and its Clinical and Histologic Bases. Scandinavian Journal of Urology and Nephrology. 3(2). 79–85. 11 indexed citations
14.
Esposti, P. L., F. Edsmyr, G. Moberger, Lars B. Wadström, & J Zajicek. (1969). Cytologic Diagnosis in Bladder Carcinoma Treated by Supervoltage Irradiation. Scandinavian Journal of Urology and Nephrology. 3(3). 201–203. 1 indexed citations
15.
Lindstedt, Sven, et al.. (1966). Studies on the Metabolism of Labeled Pyridoxine in Man. American Journal of Clinical Nutrition. 18(3). 185–196. 45 indexed citations
16.
Carlson, Lars A. & Lars B. Wadström. (1959). Determination of glycerides in blood serum. Clinica Chimica Acta. 4(2). 197–205. 250 indexed citations
17.
Wadström, Lars B.. (1957). Lipolytic Effect of the Injection of Adrenaline on Fat Depots. Nature. 179(4553). 259–260. 46 indexed citations
18.
Carlson, Lars A. & Lars B. Wadström. (1957). Studies on the glycerides during the clearing reaction. Clinica Chimica Acta. 2(1). 9–15. 28 indexed citations
19.
Wadström, Lars B., et al.. (1956). Serum Fat in Tourniquet Shock an Experimental Study in Rabbits, with Special Reference to the Action of Heparin. Scandinavian Journal of Clinical and Laboratory Investigation. 8(4). 323–328. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R. M. Buckle Breakdown of academic impact, for papers by B. McArdle Breakdown of academic impact, for papers by K. R. Bruckdorfer Breakdown of academic impact, for papers by Abraham Borkowski Breakdown of academic impact, for papers by R Mahler Breakdown of academic impact, for papers by J H Sweiry Breakdown of academic impact, for papers by L. Selmeci Breakdown of academic impact, for papers by Miho Hida Breakdown of academic impact, for papers by G. J. Johnson Breakdown of academic impact, for papers by A. Gougoux
Rankless by CCL
2026